최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Cancer research and treatment : official journal of Korean Cancer Association, v.50 no.3, 2018년, pp.883 - 893
Lee, Jun Hwa (Biomarker Branch, Research Institute, National Cancer Center, Goyang, Korea) , Kim, Yun Hwan (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea) , Kim, Kyung-Hee (Biomarker Branch, Research Institute, National Cancer Center, Goyang, Korea) , Cho, Jae Youl (Department of Genetic Engineering, Sungkyunkwan University, Suwon, Korea) , Woo, Sang Myung (Biomarker Branch, Research Institute, National Cancer Center, Goyang, Korea) , Yoo, Byong Chul (Biomarker Branch, Research Institute, National Cancer Center, Goyang, Korea) , Kim, Seung Cheol (Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea)
PurposeWe sought to develop a matrix assisted laser desorption ionization-time of flight (MALDI-TOF)-based, ovarian cancer (OVC), low-mass-ion discriminant equation (LOME) and to evaluate a possible supportive role for triple-TOF mass analysis in identifying metabolic biomarkers.Materials and Method...
1 Kim YH Kim SC Recent advances in the biomarkers for epithelial ovarian cancer J Gynecol Oncol 2011 22 219 21 22247797
2 Menon U Gentry-Maharaj A Hallett R Ryan A Burnell M Sharma A Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol 2009 10 327 40 19282241
3 Jacobs IJ Menon U Ryan A Gentry-Maharaj A Burnell M Kalsi JK Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial Lancet 2016 387 945 56 26707054
4 Buys SS Partridge E Black A Johnson CC Lamerato L Isaacs C Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial JAMA 2011 305 2295 303 21642681
5 Lee JH Yoo BC Kim YH Ahn SA Yeo SG Cho JY Lowmass-ion discriminant equation (LOME) for ovarian cancer screening BioData Min 2016 9 32 27752286
6 Lee JH Kim KH Park JW Chang HJ Kim BC Kim SY Low-mass-ion discriminant equation: a new concept for colorectal cancer screening Int J Cancer 2014 134 1844 53 24096867
7 Kim K Yeo SG Yoo BC Identification of hypoxanthine and phosphoenolpyruvic acid as serum markers of chemoradiotherapy response in locally advanced rectal cancer Cancer Res Treat 2015 47 78 89 25143052
8 Yoo BC Kong SY Jang SG Kim KH Ahn SA Park WS Identification of hypoxanthine as a urine marker for non-Hodgkin lymphoma by low-mass-ion profiling BMC Cancer 2010 10 55 20175931
9 Lorenzi M Vannoni D Leoncini R Caldarone R Marinello E The determination of urinary oxypurines as markers of gastrointestinal tumors Tumori 1987 73 289 94 3603725
10 Jung J Jung Y Bang EJ Cho SI Jang YJ Kwak JM Noninvasive diagnosis and evaluation of curative surgery for gastric cancer by using NMR-based metabolomic profiling Ann Surg Oncol 2014 21 Suppl 4 S736 42 25092158
11 Kyriakides M Rama N Sidhu J Gabra H Keun HC El-Bahrawy M Metabonomic analysis of ovarian tumour cyst fluid by proton nuclear magnetic resonance spectroscopy Oncotarget 2016 7 7216 26 26769844
12 Chan TC Howell SB Role of hypoxanthine and thymidine in determining methotrexate plus dipyridamole cytotoxicity Eur J Cancer 1990 26 907 11 2171601
※ AI-Helper는 부적절한 답변을 할 수 있습니다.